NCT06851468View on ClinicalTrials.gov

Keverprazan Combined with Amoxicillin for the Treatment of Helicobacter Pylori

NANot yet recruitingINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

September 1, 2025

Conditions
Helicobacter Pylori
Interventions
DRUG

Keverprazan

Keverprazan ：Dosage form: tablet；dose：20mg；dosage: 2 times a day；duration: 14 days

DRUG

Esomeprazole

Esomeprazole：Dosage form: capsule；dose：40mg；dosage: 2 times a day；duration: 14 days

DRUG

Amoxicillin

Amoxicillin：Dosage form: capsule；dose：1g；dosage: 3 times a day；duration: 14 days。

Trial Locations (1)

730000

KeyLabGIDiseasesGansu, Lanzhou

All Listed Sponsors
lead

Key Laboratory for Gastrointestinal Diseases of Gansu Province

OTHER

NCT06851468 - Keverprazan Combined with Amoxicillin for the Treatment of Helicobacter Pylori | Biotech Hunter | Biotech Hunter